Abstract
This chapter presents resveratrol through the multiple biological processes with a primary relation the function of a cancer cell. In contrast to the “French Paradox,” in which resveratrol is associated with the protection against coronary heart disease, a cancer cell discrepancy is linked to a large amount of experimental data without enough clinical evidence gained in clinical trials. This overview is mainly focused on tackling the molecular and pathological processes considered as important during carcinogenesis and malignant disease progression. A body of accumulating experimental evidence considering the use of resveratrol against cancer cells at the level of both a biological activity and a molecular mechanism is currently collected. Oncologists live in hope that resveratrol or a resveratrol-derivative characterized by more resistance against metabolizing enzymes will find a stable place in the armamentarium of anticancer agents or pharmacologically significant modifiers of other antineoplastic drugs in use.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
